Agency Information Collection Activities: Proposed Collection; Comment Request, 3013-3015 [2013-00585]
Download as PDF
<![CDATA[
Federal Register / Vol. 78, No. 10 / Tuesday, January 15, 2013 / Notices
and Hematology Research, National Institutes
of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: January 8, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
Substance Abuse and Mental Health
Services Administration
[FR Doc. 2013–00620 Filed 1–14–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
srobinson on DSK4SPTVN1PROD with
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Neurodevelopment and
Neuroplasticity.
Date: January 28, 2013.
Time: 1:00 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Toby Behar, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4136,
MSC 7850, Bethesda, MD 20892, (301) 435–
4433, behart@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: January 9, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–00615 Filed 1–14–13; 8:45 am]
BILLING CODE 4140–01–P
VerDate Mar<15>2010
17:00 Jan 14, 2013
Jkt 229001
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer on (240) 276–
1243.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Proposed Project: Opioid Drugs in
Maintenance and Detoxification
Treatment of Opioid Dependence—42
CFR Part 8 (OMB No. 0930–0206) and
Opioid Treatment Programs (OTPs)—
Revision
42 CFR part 8 establishes a
certification program managed by
SAMHSA’s Center for Substance Abuse
Treatment (CSAT). The regulation
requires that Opioid Treatment
Programs (OTPs) be certified.
‘‘Certification’’ is the process by which
SAMHSA determines that an OTP is
qualified to provide opioid treatment
under the Federal opioid treatment
standards established by the Secretary
of Health and Human Services. To
become certified, an OTP must be
accredited by a SAMHSA-approved
accreditation body. The regulation also
provides standards for such services as
individualized treatment planning,
increased medical supervision, and
assessment of patient outcomes. This
submission seeks continued approval of
the information collection requirements
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
3013
in the regulation and of the forms used
in implementing the regulation.
SAMHSA currently has approval for
the Application for Certification to Use
Opioid Drugs in a Treatment Program
Under 42 CFR 8.11 (Form SMA–162);
the Application for Approval as
Accreditation Body Under 42 CFR 8.3(b)
(Form SMA–163); and the Exception
Request and Record of Justification
Under 42 CFR 8.12 (Form SMA–168),
which may be used on a voluntary basis
by physicians when there is a patient
care situation in which the physician
must make a treatment decision that
differs from the treatment regimen
required by the regulation. Form SMA–
168 is a simplified, standardized form to
facilitate the documentation, request,
and approval process for exceptions.
SAMHSA believes that the
recordkeeping requirements in the
regulation are customary and usual
practices within the medical and
rehabilitative communities and has not
calculated a response burden for them.
The recordkeeping requirements set
forth in 42 CFR 8.4, 8.11 and 8.12
include maintenance of the following: 5year retention by accreditation bodies of
certain records pertaining to
accreditation; documentation by an OTP
of the following: A patient’s medical
examination when admitted to
treatment, A patient’s history, a
treatment plan, any prenatal support
provided the patient, justification of
unusually large initial doses, changes in
a patient’s dosage schedule, justification
of unusually large daily doses, the
rationale for decreasing a patient’s clinic
attendance, and documentation of
physiologic dependence.
The rule also includes requirements
that OTPs and accreditation
organizations disclose information. For
example, 42 CFR 8.12(e)(1) requires that
a physician explain the facts concerning
the use of opioid drug treatment to each
patient. This type of disclosure is
considered to be consistent with the
common medical practice and is not
considered an additional burden.
Further, the rule requires, under Sec.
8.4(i)(1) that accreditation organizations
shall make public their fee structure;
this type of disclosure is standard
business practice and is not considered
a burden.
There are no changes being made to
the forms. The reason for the reduction
in burden hours is due to more
respondents submitting information
through an online function. The forms
are available online with a unique
feature for both the SMA–162 and
SMA–168 that pre-populates certain
information within the form. This in
turn reduces the program’s time spent
E:\FR\FM\15JAN1.SGM
15JAN1
3014
Federal Register / Vol. 78, No. 10 / Tuesday, January 15, 2013 / Notices
filling out the forms as well as the staff
time spent on processing it. Also, a final
rule effective January 7, 2013, (77 FR
72752, Federal Register December 6,
2012) eliminated dispensing restrictions
for buprenorphine products used in
OTPs. As a result there OTPs will
complete and submit fewer SMA–168
forms, therefore reducing burden hours.
The tables that follow summarize the
annual reporting burden associated with
the regulation, including burden
associated with the forms.
ESTIMATED ANNUAL REPORTING REQUIREMENT BURDEN FOR ACCREDITATION BODIES
Number of
respondents
42 CFR citation
Purpose
8.3(b)(1–11) ....................................
8.3(c) ...............................................
8.3(e) ...............................................
8.3(f)(2) ...........................................
Initial approval (SMA–163) .............
Renewal of approval (SMA–163) ...
Relinquishment notification ............
Non-renewal notification to accredited OTPs.
Notification to SAMHSA for seriously noncompliant OTPs.
Notification to OTP for serious noncompliance.
General documents and information to SAMHSA upon request.
Accreditation survey to SAMHSA
upon request.
List of surveys, surveyors to
SAMHSA upon request.
Report of less than full accreditation to SAMHSA.
Summaries of Inspections ..............
Notifications of Complaints .............
Revocation notification to Accredited OTPs.
Submission of 90-day corrective
plan to SAMHSA.
Notification to accredited OTPs of
Probationary Status.
8.4(b)(1)(ii) ......................................
8.4(b)(1)(iii) .....................................
8.4(d)(1) ..........................................
8.4(d)(2) ..........................................
8.4(d)(3) ..........................................
8.4(d)(4) ..........................................
8.4(d)(5) ..........................................
8.4(e) ...............................................
8.6(a)(2) and (b)(3) .........................
8.6(b) ...............................................
8.6(b)(1) ..........................................
Sub Total .................................
54 ....................................................
Responses/
respondent
Total
responses
Hours/
response
Total
hours
1
2
1
1
1
1
1
90
1
2
1
90
6.0
1.0
0.5
0.1
6
2
0.5
9
2
2
4
1.0
4
2
10
20
1.0
20
6
5
30
0.5
15
6
75
450
0.02
9
6
6
36
0.2
7.2
6
5
30
0.5
15
6
12
1
50
6
185
300
72
185
0.5
0.5
0.3
150
36
55.5
1
1
1
10
10.0
1
185
185
0.3
55.0
........................
1,407
....................
394.20
ESTIMATED ANNUAL REPORTING REQUIREMENT BURDEN FOR OPIOID TREATMENT PROGRAMS
Number of
espondents
42 CFR citation
Purpose
8.11(b) .............................................
8.11(b) .............................................
8.11(e)(1) ........................................
Renewal of approval (SMA–162) ...
Relocation of Program (SMA–162)
Application for provisional certification.
Application for extension of provisional certification.
Notification of sponsor or medical
director change (SMA–162).
Documentation to SAMHSA for interim maintenance.
Request to SAMHSA for Exemption from 8.11 and 8.12 (including SMA–168).
Notification to SAMHSA Before Establishing
Medication
Units
(SMA–162).
Notification to State Health Officer
When Patient Begins Interim
Maintenance.
Contents of Appellant Request for
Review of Suspension.
Informal Review Request ...............
Appellant’s Review File and Written Statement.
Appellant’s Request for Expedited
Review.
Appellant Review File and Written
Statement.
8.11(e)(2) ........................................
8.11(f)(5) .........................................
8.11(g)(2) ........................................
8.11(h) .............................................
8.11(i)(1) .........................................
8.12(j)(2) .........................................
8.24 .................................................
srobinson on DSK4SPTVN1PROD with
8.25(a) .............................................
8.26(a) .............................................
8.28(a) .............................................
8.28(c) .............................................
Sub Total .................................
VerDate Mar<15>2010
17:00 Jan 14, 2013
PO 00000
Frm 00076
Fmt 4703
Total
responses
Hours/
response
Total
hours
386
35
42
386
35
42
0.15
1.17
1
57.9
40.95
42.00
1
30
0.25
7.50
60
1
60
0.1
6.00
1
1
1
1
1.00
1,200
20
24,000
0.07
1680
10
1
10
0.25
2.5
1
20
20
0.33
6.6
2
1
2
0.25
.50
2
2
1
1
2
2
1.00
5.00
2.00
10.00
2
1
2
1.00
2.00
2
1
2
5.00
10.00
1,775
Sfmt 4703
1
1
1
30
.........................................................
Jkt 229001
Responses/
respondent
....................
24,594
................
1868.95
E:\FR\FM\15JAN1.SGM
15JAN1
3015
Federal Register / Vol. 78, No. 10 / Tuesday, January 15, 2013 / Notices
ESTIMATED ANNUAL REPORTING REQUIREMENT BURDEN FOR OPIOID TREATMENT PROGRAMS—Continued
42 CFR citation
Number of
espondents
Purpose
Total ..................................
.........................................................
Send comments to Summer King,
SAMHSA Reports Clearance Officer,
Room 2–1057, One Choke Cherry Road,
Rockville, MD 20857 or email her a
copy at summer.king@samhsa.hhs.gov.
Written comments should be received
by March 18, 2013.
Summer King,
Statistician.
[FR Doc. 2013–00585 Filed 1–14–13; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HOMELAND
SECURITY
Office of the Secretary
[Docket No. DHS–2012–0034]
1,829
Responses/
respondent
....................
• Federal e-Rulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
• Fax: 202–343–4010.
• Mail: Jonathan R. Cantor, Acting
Chief Privacy Officer, Privacy Office,
Department of Homeland Security,
Washington, DC 20528.
Instructions: All submissions received
must include the agency name and
docket number for this rulemaking. All
comments received will be posted
without change to https://
www.regulations.gov, including any
personal information provided.
Docket: For access to the docket to
read background documents or
comments received, visit https://
www.regulations.gov.
For
general questions, please contact:
Laurence E. Castelli, 202–325–0280,
CBP Privacy Officer, Office of
International Trade/Regulations and
Rulings, U.S. Customs and Border
Protection, Mint Annex, 799 9th Street
NW., Washington, DC 20229–1177. For
privacy issues, please contact: Jonathan
R. Cantor, 202–343–1717, Acting Chief
Privacy Officer, Privacy Office,
Department of Homeland Security,
Washington, DC 20528.
SUPPLEMENTARY INFORMATION:
FOR FURTHER INFORMATION CONTACT:
Privacy Act of 1974; U.S. Customs and
Border Protection; DHS/CBP–004–
Intellectual Property Rights eRecordation and Search Systems,
System of Records
Department of Homeland
Security, Privacy Office.
ACTION: Notice of Privacy Act system of
records.
AGENCY:
In accordance with the
Privacy Act of 1974, the Department of
Homeland Security, U.S. Customs and
Border Protection proposes to establish
a new system of records titled, ‘‘U.S.
Customs and Border Protection, DHS/
CBP–004–Intellectual Property Rights eRecordation and Search Systems System
of Records.’’ This system of records
allows the Department and CBP to
collect and maintain records on
copyrights, trademarks, and trade names
that the respective owners have applied
to have recorded with CBP. In addition,
the Department is issuing a Notice of
Proposed Rulemaking elsewhere in the
Federal Register to exempt this system
of records from certain provisions of the
Privacy Act. This newly established
system will be included in the
Department’s inventory of record
systems.
SUMMARY:
Submit comments on or before
February 14, 2013. This new system will
be effective February 14, 2013.
ADDRESSES: You may submit comments,
identified by docket number DHS–
2012–034 by one of the following
methods:
srobinson on DSK4SPTVN1PROD with
DATES:
VerDate Mar<15>2010
17:00 Jan 14, 2013
Jkt 229001
I. Background
In accordance with the Privacy Act of
1974, 5 U.S.C. 552a, the Department of
Homeland Security (DHS), U.S. Customs
and Border Protection (CBP) proposes to
establish a new DHS system of records
titled, ‘‘DHS/CBP–004–Intellectual
Property Rights e-Recordation and
Search Systems System of Records.’’
The Intellectual Property Rights eRecordation and Search Systems
(IPRRSS) collect, use, and maintain
records related to intellectual property
rights recordations and their owners.
The purpose of IPRRSS is to aid in the
enforcement of intellectual property
rights by making intellectual property
recordations available to the public and
to CBP officials.
IPRRSS collectively encompasses
three separate systems. The first system
is the online Intellectual Property Rights
e-Recordation (IPRR) system, which
allows intellectual property owners to
submit applications for trademark and
copyright recordations. The IPRR
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
Total
responses
26,001
Hours/
response
Total
hours
................
2,263.15
system shares information with the
public Intellectual Property Rights
Search (IPRS) system and the CBP
Intellectual Property Rights Internal
Search (IPRiS) system. Because CBP
may collect personally identifiable
information (PII) about intellectual
property rights holders, their agents, or
their licensees in IPRR, IPRS, and IPRiS
(collectively IPRRSS), CBP is providing
the public notice about how CBP
collects, uses, and maintains records
related to intellectual property rights
recordations.
The authority for this system derives
from Section 42 of the Lanham Act
(Trademark Act of 1946), as amended,
15 U.S.C. 1124; Sections 101 and 602
through 603 of the Copyright Act of
1976, as amended, 17 U.S.C. 101, 602–
603; and Sections 526, 595a, and 624 of
the Tariff Act of 1930, as amended, 19
U.S.C. 1526, 1595a, and 1624. The cited
sections provide that intellectual
property rights owners may submit
information to CBP to enable CBP
officials to identify infringing articles at
the borders and prevent the importation
of counterfeit or pirated merchandise.
Owners seeking to have merchandise
excluded from entry must provide proof
to CBP of the validity of the intellectual
property rights they seek to protect.
Pursuant to the Independent Offices
Appropriations Act of 1952, 31 U.S.C.
9701, and regulations at 19 CFR 133.3,
133.13, and 133.33, intellectual property
rights owners or their agents must pay
a fee when they apply for the
recordation with CBP of their
trademark, trade name, or copyright.
Through IPRR’s web-based interface, the
user will be prompted through several
steps that capture the user’s required
application information. Once the
applicant has entered all required
application information, IPRR will
guide the applicant through a series of
prompts seeking his/her billing name,
billing address, and credit card
information. IPRR forwards this
payment information to Pay.gov for
payment processing, and the applicant
name and an IPRR tracking number to
the DHS/CBP–003 Credit/Debit Card
Data System (CDCDS) System of
Records for payment reconciliation.
Pay.gov sends a nightly activity file,
including the last four digits of the
credit card, authorization number,
billing name, billing address, IPRR
E:\FR\FM\15JAN1.SGM
15JAN1
]]>Agencies
[Federal Register Volume 78, Number 10 (Tuesday, January 15, 2013)]
[Notices]
[Pages 3013-3015]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-00585]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Proposed Collection;
Comment Request
In compliance with Section 3506(c)(2)(A) of the Paperwork Reduction
Act of 1995 concerning opportunity for public comment on proposed
collections of information, the Substance Abuse and Mental Health
Services Administration (SAMHSA) will publish periodic summaries of
proposed projects. To request more information on the proposed projects
or to obtain a copy of the information collection plans, call the
SAMHSA Reports Clearance Officer on (240) 276-1243.
Comments are invited on: (a) Whether the proposed collections of
information are necessary for the proper performance of the functions
of the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology.
Proposed Project: Opioid Drugs in Maintenance and Detoxification
Treatment of Opioid Dependence--42 CFR Part 8 (OMB No. 0930-0206) and
Opioid Treatment Programs (OTPs)--Revision
42 CFR part 8 establishes a certification program managed by
SAMHSA's Center for Substance Abuse Treatment (CSAT). The regulation
requires that Opioid Treatment Programs (OTPs) be certified.
``Certification'' is the process by which SAMHSA determines that an OTP
is qualified to provide opioid treatment under the Federal opioid
treatment standards established by the Secretary of Health and Human
Services. To become certified, an OTP must be accredited by a SAMHSA-
approved accreditation body. The regulation also provides standards for
such services as individualized treatment planning, increased medical
supervision, and assessment of patient outcomes. This submission seeks
continued approval of the information collection requirements in the
regulation and of the forms used in implementing the regulation.
SAMHSA currently has approval for the Application for Certification
to Use Opioid Drugs in a Treatment Program Under 42 CFR 8.11 (Form SMA-
162); the Application for Approval as Accreditation Body Under 42 CFR
8.3(b) (Form SMA-163); and the Exception Request and Record of
Justification Under 42 CFR 8.12 (Form SMA-168), which may be used on a
voluntary basis by physicians when there is a patient care situation in
which the physician must make a treatment decision that differs from
the treatment regimen required by the regulation. Form SMA-168 is a
simplified, standardized form to facilitate the documentation, request,
and approval process for exceptions.
SAMHSA believes that the recordkeeping requirements in the
regulation are customary and usual practices within the medical and
rehabilitative communities and has not calculated a response burden for
them. The recordkeeping requirements set forth in 42 CFR 8.4, 8.11 and
8.12 include maintenance of the following: 5-year retention by
accreditation bodies of certain records pertaining to accreditation;
documentation by an OTP of the following: A patient's medical
examination when admitted to treatment, A patient's history, a
treatment plan, any prenatal support provided the patient,
justification of unusually large initial doses, changes in a patient's
dosage schedule, justification of unusually large daily doses, the
rationale for decreasing a patient's clinic attendance, and
documentation of physiologic dependence.
The rule also includes requirements that OTPs and accreditation
organizations disclose information. For example, 42 CFR 8.12(e)(1)
requires that a physician explain the facts concerning the use of
opioid drug treatment to each patient. This type of disclosure is
considered to be consistent with the common medical practice and is not
considered an additional burden. Further, the rule requires, under Sec.
8.4(i)(1) that accreditation organizations shall make public their fee
structure; this type of disclosure is standard business practice and is
not considered a burden.
There are no changes being made to the forms. The reason for the
reduction in burden hours is due to more respondents submitting
information through an online function. The forms are available online
with a unique feature for both the SMA-162 and SMA-168 that pre-
populates certain information within the form. This in turn reduces the
program's time spent
[[Page 3014]]
filling out the forms as well as the staff time spent on processing it.
Also, a final rule effective January 7, 2013, (77 FR 72752, Federal
Register December 6, 2012) eliminated dispensing restrictions for
buprenorphine products used in OTPs. As a result there OTPs will
complete and submit fewer SMA-168 forms, therefore reducing burden
hours.
The tables that follow summarize the annual reporting burden
associated with the regulation, including burden associated with the
forms.
Estimated Annual Reporting Requirement Burden for Accreditation Bodies
----------------------------------------------------------------------------------------------------------------
Number of Responses/ Total Hours/ Total
42 CFR citation Purpose respondents respondent responses response hours
----------------------------------------------------------------------------------------------------------------
8.3(b)(1-11).................. Initial approval 1 1 1 6.0 6
(SMA-163).
8.3(c)........................ Renewal of 2 1 2 1.0 2
approval (SMA-
163).
8.3(e)........................ Relinquishment 1 1 1 0.5 0.5
notification.
8.3(f)(2)..................... Non-renewal 1 90 90 0.1 9
notification to
accredited OTPs.
8.4(b)(1)(ii)................. Notification to 2 2 4 1.0 4
SAMHSA for
seriously
noncompliant
OTPs.
8.4(b)(1)(iii)................ Notification to 2 10 20 1.0 20
OTP for serious
noncompliance.
8.4(d)(1)..................... General 6 5 30 0.5 15
documents and
information to
SAMHSA upon
request.
8.4(d)(2)..................... Accreditation 6 75 450 0.02 9
survey to
SAMHSA upon
request.
8.4(d)(3)..................... List of surveys, 6 6 36 0.2 7.2
surveyors to
SAMHSA upon
request.
8.4(d)(4)..................... Report of less 6 5 30 0.5 15
than full
accreditation
to SAMHSA.
8.4(d)(5)..................... Summaries of 6 50 300 0.5 150
Inspections.
8.4(e)........................ Notifications of 12 6 72 0.5 36
Complaints.
8.6(a)(2) and (b)(3).......... Revocation 1 185 185 0.3 55.5
notification to
Accredited OTPs.
8.6(b)........................ Submission of 90- 1 1 1 10 10.0
day corrective
plan to SAMHSA.
8.6(b)(1)..................... Notification to 1 185 185 0.3 55.0
accredited OTPs
of Probationary
Status.
---------------------------------------------------------------------------------
Sub Total................. 54.............. .............. 1,407 ........... 394.20
----------------------------------------------------------------------------------------------------------------
Estimated Annual Reporting Requirement Burden for Opioid Treatment Programs
----------------------------------------------------------------------------------------------------------------
Number of Responses/ Total Hours/ Total
42 CFR citation Purpose respondents respondent responses response hours
----------------------------------------------------------------------------------------------------------------
8.11(b)....................... Renewal of 386 1 386 0.15 57.9
approval (SMA-
162).
8.11(b)....................... Relocation of 35 1 35 1.17 40.95
Program (SMA-
162).
8.11(e)(1).................... Application for 42 1 42 1 42.00
provisional
certification.
8.11(e)(2).................... Application for 30 1 30 0.25 7.50
extension of
provisional
certification.
8.11(f)(5).................... Notification of 60 1 60 0.1 6.00
sponsor or
medical
director change
(SMA-162).
8.11(g)(2).................... Documentation to 1 1 1 1 1.00
SAMHSA for
interim
maintenance.
8.11(h)....................... Request to 1,200 20 24,000 0.07 1680
SAMHSA for
Exemption from
8.11 and 8.12
(including SMA-
168).
8.11(i)(1).................... Notification to 10 1 10 0.25 2.5
SAMHSA Before
Establishing
Medication
Units (SMA-162).
8.12(j)(2).................... Notification to 1 20 20 0.33 6.6
State Health
Officer When
Patient Begins
Interim
Maintenance.
8.24.......................... Contents of 2 1 2 0.25 .50
Appellant
Request for
Review of
Suspension.
8.25(a)....................... Informal Review 2 1 2 1.00 2.00
Request.
8.26(a)....................... Appellant's 2 1 2 5.00 10.00
Review File and
Written
Statement.
8.28(a)....................... Appellant's 2 1 2 1.00 2.00
Request for
Expedited
Review.
8.28(c)....................... Appellant Review 2 1 2 5.00 10.00
File and
Written
Statement.
---------------------------------------------------------------------------------
Sub Total................. ................ 1,775 ........... 24,594 ......... 1868.95
---------------------------------------------------------------------------------
[[Page 3015]]
Total................. ................ 1,829 ........... 26,001 ......... 2,263.15
----------------------------------------------------------------------------------------------------------------
Send comments to Summer King, SAMHSA Reports Clearance Officer,
Room 2-1057, One Choke Cherry Road, Rockville, MD 20857 or email her a
copy at summer.king@samhsa.hhs.gov. Written comments should be received
by March 18, 2013.
Summer King,
Statistician.
[FR Doc. 2013-00585 Filed 1-14-13; 8:45 am]
BILLING CODE 4162-20-P
